Appello Pharmaceuticals
TN - NashvillePharmaceutical
Focus: Appello Pharmaceuticals is a neurology-focused pharmaceutical company developing novel positive allosteric modulators targeting metabotropic glutamate receptor subtype 4. The company operates from Nashville, Tennessee with an undisclosed employee base and development stage.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Appello Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Appello Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AP-472
Parkinson DiseaseClinical Trials (1)
NCT07432958A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Phase 2Help build intelligence for Appello Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.